Inspiralia participates as a partner to a project selected to receive a €3.3 million grant in the European Innovation Council’s (EIC) Transition call. The project, called CHARM and coordinated by Cambridge Raman Imaging (CRI), aims to develop a medical device based on high-speed, low-cost Raman digital imaging technology and artificial intelligence to transform cancer diagnosis and treatment. The technology will analyse the molecular composition of patient tissue samples to distinguish cancerous from healthy cells without chemical staining.
CHARM is a pan-European collaboration between CRI, the University of Cambridge, Italian institutions Politecnico Di Milano, and Consiglio Nazionale Delle Ricerche, the Jena University Hospital in Germany, and the firms INsociety from Italy and Inspiralia from Spain. The project coordinator is Dr. Matteo Negro, CRI’s Chief Technology Officer.
CHARM is one of the 42 projects selected for funding from 292 submitted in the first-ever EIC Transition Challenges, intended to support moving technologies from laboratories into the real world. It aims to develop medical devices for the preclinical validation phase.
CHARM’s Raman imaging technology uses graphene-based ultra-fast fibre lasers to generate digital images of patient tissue for automatic analysis by artificial intelligence to support the diagnosis. Because the images are digital, they can be viewed remotely, allowing histopathologists to work more efficiently and to support regions and countries short of qualified staff. The technology also potentially opens the way for personalized cancer treatments.
The EIC is Europe’s flagship innovation Programme to identify, develop, and scale breakthrough technologies and game-changing innovations.
Inspiralia aims to provide technical delivery services to companies from all over Europe in advanced materials, computer engineering, electronics, intelligent software, computer vision, embedded systems, location-aware systems, etc. The company covers the complete product development cycle from the inception of the “idea,” conceptual design, state of the art research, and innovation, up to the construction of the prototypes, field testing, and validation. Inspiralia also offers support to bridge the gap from the research prototype to the final commercial product; by assisting our partners in dissemination, marketing, and exploitation activities.